ProCE Banner Activity

Expanding Therapeutic Choices in Atopic Dermatitis: Emerging Agents in AD: Current Evidence


The therapeutic landscape for atopic dermatitis (AD) is expanding rapidly. There are several novel agents available and more on the horizon with proven durable efficacy and favorable safety profiles. Download these slides to learn about new and emerging targeted therapies for managing AD.

Released: July 17, 2023



Victoria Garcia-Albea

Victoria Garcia-Albea, NP, DCNP

Lahey Dermatology
Director, Lahey Dermatology Nurse Practitioner Training Program
Burlington, Massachusetts

Benjamin Ungar

Benjamin Ungar, MD

Director, Alopecia Center of Excellence
Director, Rosacea & Seborrheic Dermatitis Clinic
Assistant Professor, Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, New York

Provided by

Provided by Partners for Advancing Clinical Education (PACE)

ProCE Banner


This activity is supported by educational grants from AbbVie Inc, Galderma, and Lilly.

AbbVie Inc.